We are live on ! Find out more
LC

Lindbrook Capital Portfolio holdings

AUM $1.08B
1-Year Est. Return 10.14%
This Fund
S&P 500
This Quarter Est. Return
+7.83%
1 Year Est. Return
+10.14%
3 Year Est. Return
+35.77%
5 Year Est. Return
+141.26%
10 Year Est. Return
AUM
$853M
AUM Growth
+$41.2M
Cap. Flow
-$4.27M
Cap. Flow %
-0.5%
Top 10 Hldgs %
45.97%
Holding
2,993
New
166
Increased
1,040
Reduced
961
Closed
220

Sector Composition

Rank Sector Weight
1 Financials 17.04%
2 Technology 13.3%
3 Healthcare 7.37%
4 Industrials 3.43%
5 Consumer Staples 3.24%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
AXSM icon
26
Axsome Therapeutics
AXSM
$10.9B
$5.19M 0.61%
84,221
-329
-0.4% -$21.6K
SOXX icon
27
iShares Semiconductor ETF
SOXX
$48.7B
$5.1M 0.6%
34,380
+414
+1% +$56.4K
TMO icon
28
Thermo Fisher Scientific
TMO
$220B
$4.97M 0.58%
8,622
+238
+3% +$134K
BAC icon
29
Bank of America
BAC
$442B
$4.95M 0.58%
173,023
+123,091
+247% +$4.06M
GOOGL icon
30
Alphabet (Google) Class A
GOOGL
$4.33T
$4.63M 0.54%
44,639
+2,481
+6% +$238K
XLP icon
31
State Street Consumer Staples Select Sector SPDR ETF
XLP
$14.9B
$4.62M 0.54%
61,897
+1,041
+2% +$76.1K
GOOG icon
32
Alphabet (Google) Class C
GOOG
$4.32T
$4.59M 0.54%
44,140
+680
+2% +$65.7K
HON icon
33
Honeywell
HON
$78B
$4.5M 0.53%
24,997
+348
+1% +$65.4K
IYJ icon
34
iShares US Industrials ETF
IYJ
$2.02B
$4.39M 0.51%
43,824
+242
+0.6% +$24.2K
BRK.B icon
35
Berkshire Hathaway Class B
BRK.B
$1.13T
$4.37M 0.51%
14,140
-1,112
-7% -$343K
NMFC icon
36
New Mountain Finance
NMFC
$732M
$4.35M 0.51%
357,398
+5,750
+2% +$72.4K
CHI
37
Calamos Convertible Opportunities and Income Fund
CHI
$1.05B
$4.27M 0.5%
405,814
+25,600
+7% +$295K
PPA icon
38
Invesco Aerospace & Defense ETF
PPA
$8.7B
$4.26M 0.5%
52,909
+5,540
+12% +$442K
EL icon
39
Estee Lauder
EL
$32B
$4.21M 0.49%
17,095
+155
+0.9% +$39.4K
JPM icon
40
JPMorgan Chase
JPM
$950B
$4.16M 0.49%
31,927
-161
-0.5% -$22.1K
VO icon
41
Vanguard Morningstar Mid-Cap ETF
VO
$109B
$4.16M 0.49%
78,820
CME icon
42
CME Group
CME
$94.8B
$3.99M 0.47%
20,830
-4,206
-17% -$761K
FDN icon
43
First Trust Dow Jones Internet Index Fund ETF
FDN
$5.45B
$3.85M 0.45%
26,054
+4,191
+19% +$579K
VCR icon
44
Vanguard Consumer Discretionary ETF
VCR
$6.33B
$3.77M 0.44%
14,942
+136
+0.9% +$33.1K
VOO icon
45
Vanguard S&P 500 ETF
VOO
$1.01T
$3.58M 0.42%
9,512
VT icon
46
Vanguard Total World Stock ETF
VT
$79.8B
$3.54M 0.42%
38,459
-25,584
-40% -$2.32M
XBI icon
47
State Street SPDR S&P Biotech ETF
XBI
$10.3B
$3.49M 0.41%
45,843
+675
+1% +$56K
PFE icon
48
Pfizer
PFE
$153B
$3.19M 0.37%
78,154
-1,830
-2% -$79K
NVCR icon
49
NovoCure
NVCR
$1.91B
$3.17M 0.37%
52,669
+2,315
+5% +$185K
XLK icon
50
State Street Technology Select Sector SPDR ETF
XLK
$124B
$3.16M 0.37%
41,814
+44
+0.1% +$3.03K

Similar funds

Lindbrook Capital's Q1 2023 Portfolio in Review

As of Q1 2023, Lindbrook Capital held 2,993 positions worth $853M, up 5.1% from $812M the previous quarter. Its ten largest holdings account for 46% of the portfolio.

Lindbrook Capital's Q1 2023 filing shows 166 new, 1,040 increased, 961 reduced and 220 closed positions. Its largest new stake was Hess Midstream: 4,984 shares worth $144K. The largest sale was Oramed Pharmaceuticals, an estimated $4.61M.

By sector, the portfolio is most concentrated in Financials at 17% of assets, down from 18% a quarter earlier, followed by Technology and Healthcare.

  • Lindbrook Capital's largest Q1 2023 buy was Hess Midstream: 4,984 shares worth $144K.
  • Lindbrook Capital added most to Vanguard Total International Stock ETF in Q1 2023, an estimated $12.7M increase.
  • Lindbrook Capital's biggest Q1 2023 reduction was Agenus, cutting an estimated $2.89M.
  • Lindbrook Capital fully exited Oramed Pharmaceuticals in Q1 2023, selling an estimated $4.61M.
  • Lindbrook Capital's ten largest holdings make up 46% of its $853M portfolio in Q1 2023.
  • Lindbrook Capital opened 166 new positions and closed 220 in Q1 2023.
  • Lindbrook Capital's portfolio value rose 5.1% quarter-over-quarter to $853M.

Based on Lindbrook Capital's 13F filing for Q1 2023, filed 26 Apr 2023.